Description
FUNDS NOT NEEDED -$34,532.19 OPTILITE REAGENT EXERCISING OY2 TO CORRECT UNIT PRICES FOR OY2
Base award description: OPTILITE REAGENT EXERCISING OY2
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2024-02-02+$167,039= $167,039
- Mod P000012024-09-26+$5,053= $172,092
- Mod P000022026-03-18-$34,532= $137,560
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2024-02-02 | +$167,039 | $167,039 | OPTILITE REAGENT EXERCISING OY2 |
| Mod P00001· FUNDING ONLY ACTION | 2024-09-26 | +$5,053 | $172,092 | OPTILITE REAGENT EXERCISING OY2 TO CORRECT UNIT PRICES FOR OY2 |
| Mod P00002· FUNDING ONLY ACTION | 2026-03-18 | −$34,532 | $137,560 | FUNDS NOT NEEDED -$34,532.19 OPTILITE REAGENT EXERCISING OY2 TO CORRECT UNIT PRICES FOR OY2 |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI ETZEQNG96NN5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25026N0395 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $69,423 | FY2026 |
| 36C24826N0254 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $74,121 | FY2026 |
| 36C25026F0294 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $183,301 | FY2026 |
| 36C24126N0140 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $276,000 | FY2026 |
| 36C24126A0010 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $0 | FY2026 |
| 36C26226N0172 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $428,607 | FY2026 |
Other recipients under 6515 from 250-NETWORK CONTRACT OFFICE 10 (36C250) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25026F0700 | GOVERNMENT MARKETING AND PROCUREMENT, LLC | 250-NETWORK CONTRACT OFFICE 10 (36C250) | $369,509 | FY2026 |
| 36C25026P1048 | DELTA INTERNATIONAL SERVICES & LOGISTICS (USA), INC | 250-NETWORK CONTRACT OFFICE 10 (36C250) | $84,999 | FY2026 |
| 36C25026F0687 | PENTAX OF AMERICA, INC. | 250-NETWORK CONTRACT OFFICE 10 (36C250) | $18,292 | FY2026 |
| 36C25026F0670 | A.M. COMMUNICATIONS SOLUTIONS, INC. | 250-NETWORK CONTRACT OFFICE 10 (36C250) | $19,087 | FY2026 |
| 36C25026F0680 | OLYMPUS AMERICA INC | 250-NETWORK CONTRACT OFFICE 10 (36C250) | $381,132 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25024N0314_3600_36C25022D0034_3600 · retrieved 2026-09-26.